Download item year list
Thumb Download Description
Camelback Dermatology (opens in new window)
Totality Medispa (opens in new window)
Advanced Facial Surgery (opens in new window)

Clinical Publications

Download item year list
Download Description
PrabotulinumtoxinA Versus OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines (Aesthetics Surgery Journal, 2022) (opens in new window)
PrabotulinumtoxinA for Treatment of Millennials With Moderate to Severe Glabellar Lines (Dermatologic Surgery, 2022) (opens in new window)
1/2 Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients (Aesthetic Surgery Journal, 2021) (opens in new window)
2/2 Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients (Aesthetic Surgery Journal, 2021) (opens in new window)
PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color (Dermatologic Surgery, 2021) (opens in new window)
Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients (Aesthetic Surgery Journal, 2019) (opens in new window)
Phase III Study Results for Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects (Dermatologic Surgery, 2019) (opens in new window)